Public Allocation Amounts

PLEASE NOTE: This public dashboard was created by the Directing Administrator of the Distributor Settlement Agreement, dated as of July 21, 2021; the Janssen Settlement Agreement, dated as of July 21, 2021; the CVS Settlement Agreement, dated as of December 9, 2022; the Walgreens Settlement Agreement dated as of December 9, 2022; the Walmart Settlement Agreement dated as of November 14, 2022; the Allergan Settlement Agreement dated as of November 22, 2022; and the Teva Settlement Agreement dated as of November 22, 2022 (together , the “Settlement Agreements”). All capitalized terms used in this dashboard have the meanings set forth in the Settlement Agreements.

The current allocations and payments below are the amounts that the indicated State(s) and/or Subdivision(s) have been allocated pursuant to the Settlement Agreements for prior payment years, and the amounts that have been paid to date.

The projected calculations below were prepared solely by the Directing Administrator and are the preliminary amounts that the Director Administrator has projected that the indicated State(s) and/or Subdivision(s) may receive in future payment years pursuant to the Settlement Agreements if all relevant facts and circumstances were to remain unchanged.

Please be advised, however, that the relevant facts and circumstances, including but not limited to current levels of State and Subdivision participation, are subject to change and thus, there are no guarantees regarding the amounts or timing of any future payment(s). Please also be advised that the projected calculations are complex and have not been reviewed or approved by the Settling States or the Settling Defendants. Each Settlement Agreement sets forth a process for calculating the annual payment that each Settling State will receive from each Settling Defendant, that process involves input from the Settling States and the Settling Defendants, and that process has not yet taken place for any future payment years. The amounts and timing of any future payments will be governed by the terms of the Settlement Agreements.

Payment timing and amounts are subject to change. For Distributor and Janssen, this may be affected by, among other things, increased participation in a State, a State’s eligibility for Incentive Payment D, and suspensions or offsets related to Later Litigating Subdivisions. See, e.g., Section IV, Section XII, and Section XIII of the Distributor Settlement Agreement and Section V and Section IX of the Janssen Settlement Agreement. Payment timing and amounts may also be affected by the Pre-payment Option and/or Significant Financial Constraint provisions of the Distributor Settlement Agreement (Section IV. J and Section IV. K). For CVS, Walgreens, Walmart, Allergan and Teva, this may be affected by, among other things, increased participation in a State, a State’s eligibility for Incentive Payment D, and Later Litigating Subdivisions. Payment timing and amounts may also be affected by the Significant Financial Constraint provision of the Walgreens Settlement Agreement (Section IV. K). Please also note that these projected calculations do not take into account any Settlement Fund Administrator costs and fees that exceed the available interest accrued in the Settlement Fund. Note that some Subdivisions have directed their opioid settlement funds to other Subdivisions or their State, and the current allocations and projected calculations account for those reallocations. Use the dropdown menus to select the relevant Settlement, and then from the full list of States and Territories.

If the below State elected to receive payments as a Lump Sum to later distribute to Participating Subdivisions, the allocations and projected calculations will only provide details related to those lump sum amounts. Questions related to how those Lump Sum amounts were further allocated will need to be directed to the State Attorney General’s Office.

Certain States separately settled with the Settling Distributors, Janssen, CVS, Walgreens, Walmart, Allergan, and Teva, and those payments are not reflected in this public dashboard. Further details regarding the States that separately settled can be found in the National Opioid Settlements website available at State Participation Status – National Opioids Settlement (nationalopioidsettlement.com).